KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Cash (2016 - 2026)

Palvella Therapeutics has reported Change in Cash over the past 10 years, most recently at -$9.8 million for Q4 2022.

  • Quarterly Change in Cash fell 34.3% to -$9.8 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$79.1 million through Dec 2022, down 267.19% year-over-year, with the annual reading at -$25.6 million for FY2025, 133.6% down from the prior year.
  • Change in Cash was -$9.8 million for Q4 2022 at Palvella Therapeutics, down from -$5.8 million in the prior quarter.
  • Over five years, Change in Cash peaked at $71.6 million in Q1 2018 and troughed at -$58.9 million in Q2 2018.
  • The 5-year median for Change in Cash is -$4.7 million (2021), against an average of $37850.0.
  • Year-over-year, Change in Cash crashed 1098.56% in 2018 and then soared 1770.25% in 2021.
  • A 5-year view of Change in Cash shows it stood at -$14.6 million in 2018, then soared by 210.79% to $16.2 million in 2019, then tumbled by 78.1% to $3.5 million in 2020, then crashed by 305.53% to -$7.3 million in 2021, then tumbled by 34.3% to -$9.8 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Change in Cash are -$9.8 million (Q4 2022), -$5.8 million (Q3 2022), and -$29.5 million (Q2 2022).